Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I live 12 miles away from Bloomington, MN.
Elio Motors was listed as a possible electric trike in an article headline. Couldn't read the article without paying a charge so screw them; I lost enough money on this POS. Don't know if that's what caused the rise.
What the hell?? Anybody see what is causing this undeserved jump in SP?
Correct on all counts.
Here's an update only 2 weeks old: https://lexagene.com/release/2020/lexagene-provides-a-corporate-update/
Also in post 287 there is a link for a video that is a month old. I think they are doing a good job keeping us fairly current. One thing I wish he would have touched more on is the other markets. Hopefully they are pushing hard into the vet market as they need no communication from the FDA to sell there.
I thought becoming pink current was good news...LOL.
Their website is pretty nice.
Do you have a link to that please? TIA
First, I don't think it is obvious that the company monitors this board and I actually hope they don't. 95% of the posts on Ihub are complete nonsense, filled with biased pumps and bashes, and 'experts' who know everything about everything. NOT! They are of no help to a legitimate business.
I think the holding company might be a better model, IMO. I follow many companies that are trying to get vehicles of all kinds into the air. There are a lot of them. Most people have no idea how long it takes to get a flying vehicle (plane, VTOL, car, elec, or ICE, etc.) from diagram to lift off. Designing, redesigning, test flights, adjustments, more test flights, certification, dealing with the FAA and it goes on and on. So, the HALO, though it looks 'cool', has a long way to go (years possibly) before it produces any revenue. If they can acquire, partner, or JV with another company farther along with a product, share holder value can grow much quicker. Or maybe they get lucky and they get fast-tracked by the military. Stranger things have happened... Long XERI.
What about it?
Well that run was short-lived. What a surprise...
Well here we are a year later. A couple of us still around. Lots of BS posted here a year ago about PPS. Now we've got a nice runup today and hopefully a strong follow through in the coming month.
Wow, are these numbers really accurate? There are basically no shares to trade out there!
Well, they are trading again. Not much excitement though. Put in a low bid but didn't get filled. Pretty good volume at 730k.
Everyone get together and short the sh*t out of this P.O.S. Run these crooks into the ground. I've never seen a more inept bunch of sleazebags running a company.
My question is a legitimate question. Yes, I see these share holder lawsuits all the time. It's always the same law offices too, it seems. Some amount to something and some just fade away. Stock prices tank at these announcements or investors seem to ignore them in other instances. Seeking Alpha brought up some disturbing points in their analysis. So again, a legit question.
BTW, Apple can afford to deal with lawsuits - WRAP cannot.
Is "Notice of Allowance" and "issued a patent" the same or not?
So, do we all just ignore the lawsuits...?
Latest video update of LXXGF progress:
https://vimeo.com/460053894
Just read about Boeing: "Boeing is halting operations at Boeing NeXt — its 2-year-old innovation unit focused on futuristic manned and unmanned air mobility — as it cuts spending on peripheral projects."
I was right. There was a short attack near its peak by White Diamond Research. Don't know if they've called off the dogs yet but the Sept calls are in the toilet.
Isn't this old news? I thought they had applied for the EUA already and we were waiting for the acceptancce from the FDA. We can't sell while waiting for the OK from the FDA, can we? If they came back with a negative on the EUA, we'd have to cancel all sales that were completed.
Supposedly they're at it now. The FDA emergency OK has to be given before they can sell to human clinical market but they can sell to any of the other markets they are targeting: veterinary, agriculture, water safety, open source, etc. The FDA OK is expected by the end of this month.
Why this POS is trading at .50 is beyond me. There are stocks on the OTC trading at a coupla pennies that have more going on than elio. You are a HUGE disappointment, Mr. Elio!
More News with attachments probably on the website: https://www.ventripoint.com
Dear Friend;
It has been a long time coming but we are back! or almost there as you will read in the attached news release. Here is some background:
1. The Company asked to have its stock halted December 12, 2019 - we were NOT suspended by the Exchange.
2. We received approval to stay halted until we completed the $1,220,000 private placement, which we did last Friday. No one expected it to take so long but COVID-19 disrupted everyone’s plans.
3. The Company actually benefited overall from the pandemic, which you will read about, but briefly we had more access to cardiologist and received a lot of government support (like many other companies). This allowed us to make major changes to almost every aspect of the VMS+3.0 to lower the barrier to adoption, reduce manufacturing costs, accelerate analysis and rewrite the entire source code. The key initiatives attachment is a long read (5 pages), but worth the time.
4. The major advantage of all this work is we no longer have to go to a hospital to install the machine, calibrate the probes and train the staff. It is all done remotely now. You will read about all the advantages this approach has created for us and our customers.
5. The hospitals, while focused on COVID, did continue in their processes to acquire a VMS+3.0 and so we have 11 major hospitals ready to acquire a system as soon as they re-open their echo labs. This is starting to happen as hospitals have to start dealing with regular cardiac patients.
6. We now know COVID wrecks havoc with the heart, especially the right side, and so cardiologists are very interested in our capabilities as they fear the heart problems induced by COVID could go on for decades.
7. Lots more news to come and lots more information on what we have been doing and why it is important on our revamped website and in the addendum..
8. We are in the final stages of the TSXV Exchange review to allow us to resume trading and so I expect that will happen very soon.
I am very thankful for all the people who encouraged me to keep going. It has not been a lot of fun, but we are in a very good place right now - a way ahead of where we were before we restructured. Our team has done remarkable things in the last 9 months and the responses we are seeing from cardiologists are reflecting that we have finally gotten through all the barriers to adoption with a device that is user-friendly and fits perfectly into the workflow of an echocardiography lab. I look forward to telling you all about the wonderful effects doctors with the VMS+3.0 are having on their patients, as well as how well the company is progressing to build value for its shareholders.
As usual, I thank you for your support and interest and if you have any questions or comments, email, text, call.
Regards,
Dr. George Adams ICD.D
Executive-Chairman
Ventripoint Diagnostics Ltd.
Yes, I've been on an email list from Adams. There was a PR attached to the email. It is probably at their website. I'm kinda concerned about the convertible debentures that made up this $1.22M offering. Toxic financing?? It's explained in the PR but it is greek to me.
Here is the email I received just now:
Attached is the news release for today documenting we have closed the second tranche of $495,000 of the private placement to complete the round (which we announced many months ago) with total gross proceeds of $1,220,000.
Here is some background:
1. The Company halted trading and ceased operations in December 2019 to restructure with a new Board and the return of Dr. Adams as acting CEO.
2. The Company closed a first tranche of the $1,220,000 financing February 9 ,2020 with proceeds of $725,000 and resumed operations with all key employees returning to work.
3. In March 2020, COVID-19 pandemic reached Canada and Company ceased manufacturing and fulfillment of orders to hospitals as hospitals were focused on COVID-19 operations.
4. The Company has been focused on eliminating barriers to adoption and enabling remote installation and training.
5. As of Sept 11, 2020 the Company has closed its financing with the remaining $495,000 of proceeds and now has the funds to fulfill its existing and forthcoming purchase orders (more about this in next NR).
6. The Company is in a “Resumption Review” with the TSXV Exchange and expects to be trading in the next few days and will provide a comprehensive corporate update prior to the resumption of trading.
As usual, if you have questions call me.
Regards,
Dr. George Adams ICD.D
Executive-Chairman
Ventripoint Diagnostics Ltd.
Like Adams said, there are shareholders who want to get out, too. I'm curious as to what price the MMs will open trading at. Looks like the last trade was around a penny. I just found this company so I have no shares. Naturally I'd like to see it open as low as possible in order to get a good starter position. I think a partnership with a biggie is one of the announcements coming. Also, maybe an equipment upgrade or improvement. This is very similar to Lexagene, a medical device company, just starting commercialization. Even the price point of $50,000 is the same before discounts.
This company has turned itself around and is about ready to rock! They've already had installs in several locations. Here is an up-to-date video with Dr. Adams filmed on Sept. 9, 2020. Any day now, maybe Monday, it will start trading again.
A second interview I found where Jack speaks as a scientist rather than a CEO. The subject being vaccines vs/and testing. So if you like to hear Jack speak:
This interview is good thru and thru but it is two hours long, the first half covering what you've probably heard before. So if you don't have the time to view it all, I recommend starting at the Q&A roughly at the 1:09:00 mark. Jack really gives out some desired information from there to the end. And remember, this is already a month and a half old.
Sept. will be a big month for us. Not only will the first sales be completed but the FDA study is expected to be done by the 30th. If that doesn't happen we just concentrate our sales on the veterinarian market until the FDA gives us the green light. Revenues start flowing in during October/November. I doubt we can demand cash upfront... Sounds like numerous speaking engagements are on the calendar as well. Gotta get the word out.
Found this video dated July 24. Haven't listened yet but will shortly.
I suppose they are looking at this product as a threat to their easy, free money train (lawsuits against cities and PDs). No other reason for not wanting this device dispatched with haste all over the world. Absolutely disgusting! Pretty sad investors choose to listen to that BS and sell.
Quote: "Eye-balling it, it would take about a month for the death cross at these valuations. Hard to imagine that Q2 would be held up that long or results so poor that the stock price doesn’t move up.
In other words, ain’t happin’."
Hmmmm...
Anybody have any insight or thoughts as to why this stock has turned so erratic? It looks like there is more short interest and that's all I can come up with. Profit taking from the rocket ship it was earlier this year? Whatever, it is not much fun anymore when it goes down with ever expanding revenues...
Hope you're right, then my Oct. 7.50, and Jan. 10 and 12.50 calls will be worth a nice chunk of change!
Don't count on it. They have made similar announcements in the past and the stock price has done zilch. I get the impression the market doesn't trust Riccardo.
I have no problem trading any of these sub penny stocks on both TD Ameritrade and Charles Schwab.
New orders here, new orders there. Everyone loves it and is buying. But the stock tanks over 40% in less than a month! In a positive news environment. What gives? Short sellers? SP got ahead of itself? Damn frustrating!